Lower Drug Prices Aren't Worth Higher Health Risks

Libby Baney co-authored an article with Thomas E. Menighan, BSPharm, MBA, FAPhA for Drug Topics on the importance of patient safety instead of more affordable medication. 

"While we share the goal of increasing patient access to safe, affordable medicine, the potential cost-saving benefits of importation policies must be sufficiently weighed to account for the considerable risks to patients."Baney and Menighan, drug topics